Bulletin
Investor Alert

New York Markets Close in:

EyePoint Pharmaceuticals Inc.

NAS: EYPT

GO
/marketstate/country/us

Market open

 --Real time quotes

Sep 29, 2022, 1:22 p.m.

/zigman2/quotes/210537129/composite

$

7.38

Change

-0.27 -3.53%

Volume

Volume 19,078

Real time quotes

/zigman2/quotes/210537129/composite

Previous close

$ 7.65

$ 7.38

Change

-0.27 -3.53%

Day low

Day high

$7.35

$7.65

Open

52 week low

52 week high

$6.91

$21.50

Open

Scott Jones

Scott Jones is Chief Commercial Officer & Senior Vice President at EyePoint Pharmaceuticals, Inc.

In his past career he held the position of President for QLT Ophthalmics, Inc., Executive Director-Health Policy at Novartis Pharmaceuticals Corp., Executive Director & Head-Market Access at Novartis Ophthalmics, Inc. and Chief Commercial Officer & VP-Business Development at Notal Vision, Inc.

Scott Jones received a graduate degree and an undergraduate degree from the University of Florida.

Transactions

Date Shares Transaction Value
06/30/2020 14,060   Derivative/Non-derivative trans. at $0.76 per share. 10,686
06/30/2020 41,050   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Jay S. Duker
Chief Operating Officer
Mr. George O. Elston
CFO & Head-Corporate Development
Dr. Said Saim
Chief Technology Officer
Dr. Dario A. Paggiarino
Chief Medical Officer & Senior Vice President
Ms. Jennifer Leonard
Chief People Officer & Senior Vice President-IT
Mr. Scott Jones
Chief Commercial Officer & Senior Vice President
Mr. Michael C. Pine
Chief Corporate Development & Strategy Officer
Mr. Ye Liu
Director
Dr. Anthony P. Adamis
Director
Ms. Karen L. Zaderej
Director
Mr. Ron I. Honig
Secretary, Chief Legal Officer & Senior VP
Ms. Isabelle Lefebvre
Chief Regulatory Officer
Dr. Göran Albert Torstensson Ando
Non-Executive Chairman
Ms. Wendy F. DiCicco
Independent Director
Dr. John Barry Landis
Independent Director
Dr. David R. Guyer
Independent Director
Link to MarketWatch's Slice.